IL-6 and Ovarian Cancer-Response

被引：2

作者：

Balkwill, Frances R. ^{[1
]}

Coward, Jermaine ^{[1
]}

Kulbe, Hagen ^{[1
]}

Milagre, Carla ^{[1
]}

Gopinathan, Ganga ^{[1
]}

McNeish, Iain A. ^{[1
]}

机构：

[1] Queen Mary Univ London, John Vane Sci Ctr, Barts Canc Inst, London EC1M 6BQ, England

来源：

CLINICAL CANCER RESEARCH | 2011年 / 17卷 / 24期

关键词：

D O I：

10.1158/1078-0432.CCR-11-2680

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：7838 / 7838

页数：1

相关论文

共 6 条

[1]

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment [J].

Blank, Stephanie V. ;

Christos, Paul ;

Curtin, John P. ;

Goldman, Noah ;

Runowicz, Carolyn D. ;

Sparano, Joseph A. ;

Liebes, Leonard ;

Chen, Helen X. ;

Muggia, Franco M. .

GYNECOLOGIC ONCOLOGY, 2010, 119 (03) :451-456

[2]

Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer [J].

Coward, Jermaine ;

Kulbe, Hagen ;

Chakravarty, Probir ;

Leader, David ;

Vassileva, Vessela ;

Leinster, D. Andrew ;

Thompson, Richard ;

Schioppa, Tiziana ;

Nemeth, Jeffery ;

Vermeulen, Jessica ;

Singh, Naveena ;

Avril, Norbert ;

Cummings, Jeff ;

Rexhepaj, Elton ;

Jirstrom, Karin ;

Gallagher, William M. ;

Brennan, Donal J. ;

McNeish, Iain A. ;

Balkwill, Frances R. .

CLINICAL CANCER RESEARCH, 2011, 17 (18) :6083-6096

[3]

Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer [J].

Dorff, Tanya B. ;

Goldman, Bryan ;

Pinski, Jacek K. ;

Mack, Philip C. ;

Lara, Primo N., Jr. ;

Van Veldhuizen, Peter J., Jr. ;

Quinn, David I. ;

Vogelzang, Nicholas J. ;

Thompson, Ian M., Jr. ;

Hussain, Maha H. A. .

CLINICAL CANCER RESEARCH, 2010, 16 (11) :3028-3034

[4]

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling [J].

Jones, Simon A. ;

Scheller, Juergen ;

Rose-John, Stefan .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09) :3375-3383

[5]

IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer [J].

Lo, Chi-Wen ;

Chen, Min-Wei ;

Hsiao, Michael ;

Wang, Shiuan ;

Chen, Chi-An ;

Hsiao, Sheng-Mou ;

Chang, Jeng-Shou ;

Lai, Tsung-Ching ;

Rose-John, Stefan ;

Kuo, Min-Liang ;

Wei, Lin-Hung .

CANCER RESEARCH, 2011, 71 (02) :424-434

[6]

JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling [J].

Song, Lanxi ;

Rawal, Bhupendra ;

Nemeth, Jeffrey A. ;

Haura, Eric B. .

MOLECULAR CANCER THERAPEUTICS, 2011, 10 (03) :481-494